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A B S T R A C T
Background: The progression and severity of COVID-19 vary significantly in the population. While the
hallmarks of SARS-CoV-2 and severe COVID-19 within routine laboratory parameters are emerging, the
impact of sex and age on these profiles is still unknown.
Methods: A multidimensional analysis was performed involving millions of records of laboratory
parameters and diagnostic tests for 178 887 individuals from Brazil, of whom 33 266 tested positive for
SARS-CoV-2. Analyzed data included those relating to complete blood cell count, electrolytes,
metabolites, arterial blood gases, enzymes, hormones, cancer biomarkers, and others.
Findings: COVID-19 induced similar alterations in laboratory parameters in males and females. CRP and
ferritin were increased, especially in older men with COVID-19, whereas abnormal liver function tests
were common across several age groups, except for young women. Low peripheral blood basophils and
eosinophils were more common in the elderly with COVID-19. Both male and female COVID-19 patients
admitted to intensive care units displayed alterations in the coagulation system, and higher values for
neutrophils, CRP, and lactate dehydrogenase.
Conclusions: Our study uncovered the laboratory profiles of a large cohort of COVID-19 patients, which
formed the basis of discrepancies influenced by aging and biological sex. These profiles directly linked
COVID-19 disease presentation to an intricate interplay between sex, age, and immune activation.
$ Big Data analysis of laboratory results from a large number of COVID-19 patients and controls revealed distinct disease profiles influenced by age and sex, which may
underly the occurrence of severe disease.
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Introduction
The new coronavirus SARS-CoV-2 has spread rapidly through-
out the world, causing an unprecedented pandemic. As of February
2021, Brazil was the third-highest country in terms of number of
infections and the second in terms of cumulative deaths, with a
total of more than 10 million COVID-19 (coronavirus disease 2019)
cases and over 250 000 deaths (WHO, 2021). The virus is easily
transmitted between humans and triggers a wide spectrum of
clinical manifestations (Guan et al., 2020a, b), ranging from
asymptomatic or mild illness to severe disease. SARS-CoV-2
infection has been associated with respiratory, gastrointestinal,
hepatic, and neurological dysfunction, which can lead to acute
respiratory distress syndrome, multiple organ failure, and death in
severe cases (Tay et al., 2020).
Since SARS-CoV-2 is a systemic infection, inflammatory
responses can induce changes in the cellular and biochemical
composition of the peripheral blood (Tay et al., 2020). For instance,
a significant proportion of patients exhibit a variety of alterations
in distinct organs, such as the gastrointestinal tract (Ng and Tilg,
2020), liver (Feng et al., 2020), kidneys (Ronco et al., 2020), and
heart (Zheng et al., 2020). Such extrapulmonary manifestations are
associated with potential alterations in circulating levels of several
biochemical parameters, such as bilirubin, urea, creatinine,
myoglobin, and coagulation factors.
COVID-19 also shows sexual disparity with regard to morbidity
and mortality. A sex-stratified analysis revealed that, even after
adjusting for age, the effects of comorbidities on COVID-19
mortality were higher in men compared with women (Dudley
and Lee, 2020). This disparity can be explained by a combination of
factors, such as biological differences (chromosomal, hormonal,
etc.) and gender-specific behavioral factors, as well as pre-existing
rates of comorbidities (Gebhard et al., 2020; Haitao et al., 2020).
Therefore, it is expected that the results of laboratory assays may
vary according to sex and age.
To date, no systematic analysis of blood parameters has been
performed on a large number of COVID-19 patients, and
particularly in the context of age- and sex-related changes
observed in the absence of SARS-CoV-2 infection. By analyzing
millions of records of laboratory parameters from over 30 000
subjects infected with SARS-CoV-2 from two hospitals and one
diagnostics company in Brazil (collected between February 26,
2020—when the pandemic reached Brazil—and June 30, 2020), our
study revealed unique profiles for males and females with COVID-
19, across different ages. Such large-scale analysis may provide
critical information on COVID-19 pathogenesis related to sex and
age. Our study also showed that the combination of several
biochemical parameters and surrogates of inflammatory responses
may be used to assess disease severity.
Materials and methods
Dataset
Three publicly available datasets from the ‘COVID-19 Data
Sharing/BR’ repository, which contains information about labora-
tory parameters and demographics, as well as diagnostic tests,
were downloaded at: https://repositoriodatasharingfapesp.uspdi-
gital.usp.br/ (2020-06-30). The repository is an initiative of the São
Paulo Research Foundation (FAPESP), in collaboration with the
University of São Paulo and with the participation of the Fleury
Institute, Sírio-Libanês Hospital and the Israelita Albert Einstein
Hospital. The data for individuals with COVID-19 were collected
from February 26, 2020 to June 30, 2020, whereas the control data
(individuals without COVID-19) were collected from November 1,
2019 to June 30, 2020. The names of the laboratory tests were
translated into English and the common tests performed by the
three sites were identified. If a given test was carried out more than
once for the same subject, the result for the one performed at the
earliest date after positive diagnosis of SARS-CoV-2 (by PCR or IgM)
was collected. Only 271 individuals were diagnosed with COVID-
19, based solely on a positive IgM assay. For the COVID-19 cases,
records collected before the day of positive diagnosis of SARS-CoV-
2 or that were collected over 15 days after the day of positive
diagnosis of SARS-CoV-2 were removed. Laboratory parameters
measured in fewer than 100 subjects or that contained discrete (i.e.
categorical) values were also removed from the analysis.
Univariate analysis
The Anderson–Darling normality test was used to identify
normally distributed laboratory parameters. The Student t-test
was used to identify the changes between groups of samples, with
p-values adjusted for multiple testing using the Benjamini and
Hochberg method. The cutoffs used to identify a significant change
were an adjusted p-value < 0.05 and a log2 fold change >0.4.
Comparisons with fewer than 20 samples in both groups (i.e.
COVID-19 cases and controls) were not considered. Plots were
created using the ggplot2 R package (https://ggplot2.tidyverse.org)
and edited in CorelDraw software.
Temporal age profiling
For each year of age (stratified by sex and COVID-19 diagnostic),
the median and 95% confidence interval for each laboratory
parameter were calculated. Using ggplot2 R, a smooth line (loess
method) was fitted on the points and the lines for recent infection
vs no infection were compared for each sex, using the Kolmogorov–
Smirnov test (FDR cutoff <0.01). Ages with two or fewer values
were not included in the median calculation.
Intensive care unit (ICU) analysis
The Sírio-Libanês Hospital had identified data from patients
admitted to the ICU (n = 285). For each subject, the first date
recorded as when laboratory data were collected in the ICU was
considered as day 0. The median and 95% confidence interval for
each laboratory parameter on each day were calculated for male
and female patients. Reference normal values of the parameters
were obtained from physicians and displayed on the graphs.
Finally, specific laboratory parameters were grouped into bio-
markers of disease activity.
Results
Laboratory parameter data from two hospitals and one
diagnostics company in Brazil were made publicly available by
the São Paulo Research Foundation (FAPESP). The repository holds
open-access anonymized data for 175 887 individuals tested for
SARS-CoV-2, of which 39 391 had tested positive using a
combination of IgM/IgA/IgG serology and RT-PCR tests (Supple-
mental Figure 1A). RT-PCR or IgM tests were positive in 33 266
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subjects, suggesting recent infection with SARS-CoV-2, and were
herein defined as COVID-19 cases. All remaining individuals were
classified as controls, including the 6125 subjects who showed IgA
(N = 900) or IgG (N = 5225) seroreactivity towards SARS-CoV-2
antigens. The age distributions of male and female COVID-19 cases
were similar (Supplemental Figure 1B). In total, over 4.5 million
records of 434 laboratory parameters and diagnostic tests were
analyzed (see methods).
The subjects were divided into three age groups: 0–12 years old
(N = 5218), 13–60 years old (N = 146 404), and 61 years old (N = 22
657). Age information was not available for 1608 individuals.
Univariate analyses were then performed to compare values of
laboratory parameters between COVID-19 cases and controls
within each age group. No significant differences were found
between females and males in the 0–12 years group (Supplemental
Table 1). COVID-19 induced more alterations in the laboratory
parameters in males compared with females in those between 13
and 60 years old, in contrast with older individuals, where several
parameters were altered by COVID-19 in both men and women
(Figure 1). Male and female COVID-19 patients had a lower levels of
basophils and eosinophils, as well as significantly higher levels of
gamma-glutamyl transferase (GGT), C-reactive protein (CRP), and
ferritin when compared with control individuals in the same age
group (Figure 1, Supplemental Table 1).
A profile of key clinical chemistry parameters for male and
female COVID-19 cases compared with control cases was
generated across age groups (Figure 2). The analysis revealed
important differences relating to age and sex, even in the absence
of COVID-19. While alterations in several parameters were seen in
COVID-19 cases, the absolute levels were critically dependent on
whether patients were male or female, with the most perturbed
laboratory markers found in male COVID-19 cases (Figure 2).
The absolute counts of cell populations for the complete blood
count profile in COVID-19 cases and controls were compared by sex
and age (Figure 3). Lower counts of platelets, basophils,
lymphocytes, and eosinophils were observed in COVID-19 cases
compared with controls in both males and females (Figure 3).
Two hundred and eighty-five COVID-19 patients were admitted
to the intensive care unit (ICU). The median number of days in ICU
was 15 (Figure 4A), and 74% of patients were male (Figure 4B), with
165 individuals aged 60 years of age (range 20–88) (Figure 4C).
Daily changes in laboratory parameters during ICU stay were
Figure 1. Alterations induced by COVID-19. Volcano plots showing the differences in the levels of laboratory parameters between COVID-19 cases and controls. Female
subjects are shown on the top and male subjects on the bottom. The age group is indicated above each volcano plot and the number of individuals is shown in parenthesis. The
x-axis shows the log2 fold changes between COVID-19 cases and controls, and the y-axis shows thelog10 adjusted p-values for the analyzed laboratory parameters (dots). Red
and blue dots show, respectively, the laboratory parameters that were significantly higher or lower in COVID-19 cases compared with controls (adjusted p-value <0.05 and
log2 fold change >0.4).
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examined, with several remaining significantly altered throughout
this period compared with reference values for age (Figure 4D and
S2). Significant elevation of the coagulation markers activated
partial thromboplastin time (aPTT) and prothrombin time (PT/INR)
was seen. While aPTT values detected in critically ill male COVID-
19 patients returned back to normal after 30 days in ICU, they
remained altered in female COVID-19 patients in ICU (Figure 4D).
The curve for aPTT followed a similar trend as the curve for lactate
Figure 2. Selected laboratory parameter temporal profiles for male and female COVID-19 patients. The x-axis shows the age of individuals and the y-axis shows the fitted
median values (thick line) for the laboratory parameter displayed above each graph. The shaded area represents the 95% confidence interval. Female COVID-19 cases and
controls are shown as red and brown lines, respectively. Male COVID-19 cases and control cases are shown as dark blue and light blue lines, respectively. The number of
individuals (N) utilized in the analysis, and the Kolmogorov–Smirnov test p-value (K.S.) between the COVID-19 curve and the control curve for each sex are indicated.
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dehydrogenase (LDH) (Figure 4D), reinforcing the link between
activation of coagulation and inflammatory pathways.
Patients with COVID-19 may present with very different
complications, such as liver or kidney impairment (Gholizadeh
et al., 2020; Hong et al., 2020), systemic inflammation (Gao et al.,
2020), and coagulopathy (Franchini et al., 2020). The laboratory
parameters were manually classified into biomarkers of disease
activity, including organ damage, problems in lipid or glucose
Figure 3. Analysis of complete blood count tests in COVID-19 cases. The x-axis shows the age of individuals and the y-axis shows the fitted median values (thick line) for the
cell type displayed above each graph. The shaded area represents the 95% confidence interval. Female COVID-19 cases and controls are shown as red and brown lines,
respectively. Male COVID-19 cases and control cases are shown as dark blue and light blue lines, respectively. The number of individuals (N) utilized in the analysis, and the
Kolmogorov–Smirnov test p-value (K.S.) between the COVID-19 curve and the control curve for each sex are indicated.
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metabolism, systemic inflammation, coagulation, and acid–base
imbalance in blood gases (Supplemental Table 2). Then, for each
COVID-19 patient, the earliest recorded levels of laboratory
parameters after positive diagnosis were compared with the
respective reference values by sex. Alterations were similar
between male and female COVID-19 patients who were admitted
to ICU (Figure 5A). For instance, alterations in the frequency of
immune cells were detected in 98% of both male and female
Figure 4. Time course analysis of COVID-19 patients in ICU. (A) Number of days in ICU. Each patient is represented by a green line. The dashed vertical line shows the median
number of days in ICU. (B) Number of female and male patients in ICU. Males are represented in blue and females in pink. (C) Age distribution of patients in ICU. (D) Daily
records of laboratory parameters in patients admitted to to ICU. The dashed vertical line represents the day of the first record in ICU. Values are shown on the y-axis and the
units are displayed in parenthesis on top of each graph. The blue and pink lines represent the median values for male and female COVID-19 patients in ICU, respectively. The
shaded area represents the 95% confidence interval. Horizontal dashed lines mark the upper and lower reference normal values for males (blue) and females (pink).
F. ten-Caten, P. Gonzalez-Dias, I. Castro et al. International Journal of Infectious Diseases 105 (2021) 579–587
584
COVID-19 patients (Figure 5A). While 50.4% of male COVID-19
patients showed evidence of coagulopathy, only 39.7% of female
patients had similar abnormalities (Figure 5A). When only ICU
patients were considered, these numbers increased to 91.3%
(males) and 82.8% (females) (Figure 5A). Furthermore, a large
fraction of ICU patients showed evidence of elevated liver function
tests and renal impairment, as well as disturbances of the acid–
base balance and systemic immune response (Figure 5B). Ten
laboratory parameters were altered in a larger fraction of ICU
patients compared with all COVID-19 patients not admitted to the
ICU. These included CRP, IL-6, neutrophils, ESR, fibrinogen, glucose,
LDH, transferrin saturation (TS), albumin, and total iron binding
capacity (TIBC) (Figure 5C). These parameters further indicate that
COVID-19 severity is directly linked to disturbances in coagulation
and in the systemic immune response.
Discussion
Our in-depth analysis of routinely collected laboratory param-
eters in individuals with COVID-19 revealed that the changes seen
were critically dependent on age and sex. This has significant
implications for understanding the pathogenesis of COVID-19, as
well as for developing predictive models of SARS-CoV-2 infection
and severe disease. For instance, our results showed that elderly
male patients have significantly more abnormal laboratory values,
including higher levels of inflammatory markers, compared with
elderly females. The disproportionate male-to-female ratios of
SARS-CoV-2 infection prevalence, morbidity, and mortality have
not been reported around the world (Scully et al., 2020). Severity
and case fatality rates are significantly higher among men than
women (Michelozzi et al., 2020; Qian et al., 2020).
Recent studies have considered the role of biological sex
differences in explaining differences in outcome (Ding et al.,
2020). Sex hormones mediate differences in innate immune cells
and functional responses to SARS, MERS, influenza, and other
viruses in the respiratory tract (Karlberg et al., 2004; Channap-
panavar et al., 2017; Kadel and Kovats, 2018). Our findings provide
further support for exploring these hormonal influences in SARS-
CoV-2 outcome, in order to explain why premenopausal women
may be relatively protected from severe COVID-19 compared with
men.
Increased levels of markers such as CRP, ferritin, fibrinogen,
LDH, and GGT could be detected in many COVID-19 patients.
Ferritin and CRP have been widely described as consequences of
the production of pro-inflammatory cytokines, such as IL-6, and
the complement activation that may contribute to the systemic
inflammatory response in patients with COVID-19 (Risitano et al.,
2020). These changes were most marked in older men, although
once patients were admitted to ICU, very similar profiles were
observed between men and women.
Figure 5. Biomarkers of disease activity in COVID-19 patients. (A) Fraction of patients with altered biomarkers of disease activity. Alterations in at least one laboratory
parameter for each biomarker of disease activity were detected for male (left) and female (right) COVID-19 patients who were admitted (purple) or not admitted (yellow) to
ICU. The graph shows the subjects with alterations as a fraction of the total number of subjects. (B) Number of biomarkers of disease activity detected in COVID-19 patients.
The purple and yellow lines indicate, respectively, the fractions of COVID-19 patients who were admitted or not admitted to ICU. (C) Laboratory parameters altered in ICU
COVID-19 patients. Each bar represents the fraction of individuals who were admitted (left) or not admitted (right) to ICU, showing values above (red) or below (blue) the
normal levels for a specific parameter. Numbers of individuals with alterations are indicated.
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Our findings from complete blood count analysis revealed that
both male and female COVID-19 patients had low levels of
platelets, basophils, and eosinophils. Platelet numbers reduced
with age in both men and women, with a similar reduction in
COVID-19 patients compared with controls across age and sex.
Thrombocytopenia is thought to be an early predictor of disease
severity (Arachchillage and Laffan, 2020; Bomhof et al., 2020; Zhou
et al., 2020). While lymphopenia is considered a feature of COVID-
19, our analysis shows that the reduction in cell count is modest
compared with patients without SARS-CoV-2 of a similar age and
same sex. Little is known about the roles of basophils and
eosinophils in COVID-19. Eosinophils may enhance antiviral
immunity during infection, and can activate viral antigen-specific
CD8+ T cells (Samarasinghe et al., 2017). Moreover, previous
studies suggest that female sex hormones regulate eosinophil
numbers both in vitro and in vivo (Kadel and Kovats, 2018). Using
989 patients, Li et al. reported that eosinopenia and elevated CRP
effectively distinguish SARS-CoV-2-positive patients from SARS-
CoV-2-negative patients with COVID-19-like symptoms (Li et al.,
2020). Using hematological data from over 30 000 people across all
ages, our study demonstrated that eosinopenia and low levels of
basophils were more accentuated in COVID-19 patients compared
with other hematological parameters, especially in men older than
25 years of age.
The major limitation of our study was the lack of information
regarding patient comorbidities and clinical outcomes, other than
admission to ICU. Patients admitted to ICU or those who died from
COVID-19, as well as those with comorbidities increasing the risk
of severe disease (Guan et al., 2020a, b), may display substantial
variation in laboratory markers (Velavan and Meyer, 2020).
Overall, several of the observed abnormalities were accentuated
in patients admitted to ICU, although our study identified 10
markers that appeared to be more perturbed than others when
compared with patients with COVID-19 not admitted to ICU.
Interestingly, this included an elevated neutrophil count, which
was not significantly different between COVID-19 and control
patients overall. This may be related to increased bacterial
coinfection in COVID-19 ICU patients, but also highlights potential
differences between biomarkers associated with SARS-CoV-2
infection and those related to more severe disease. We also
acknowledge that the differences seen in the temporal profiles may
fall on a spectrum. Even though some laboratory values in COVID-
19 patients fell in the normal range, they differed significantly from
those in patients without COVID-19.
Another important limitation of our work is that we considered
individuals positive for IgM as cases of recent infection. IgM assays
may produce a high number of false positive cases, as IgM
antibodies frequently appear later in the acute process (when PCR
results is already negative). However, only a very small fraction of
the COVID-19 cases here (N = 271) was based solely on an IgM
positive assay.
We also did not have information regarding the causes of any
illness in the control group—the individuals without SARS-CoV-2
infection. It is important to remember that the differences we
describe for COVID-19 may have been relative to individuals with
other infections and not necessarily healthy controls. This is,
however, also a key strength of our study when considering the
utility of our findings for predictive models of SARS-CoV-2
infection and COVID-19-specific severity markers.
By analyzing both soluble and cellular markers in a large
number of individuals, our study demonstrated that age and sex
influenced the results for the laboratory parameters measured and
monitored in COVID-19 patients. Our findings should help guide
further studies into COVID-19 pathogenesis, as well as the
development of predictive models of SARS-CoV-2 infection and
severe disease.
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